Market Overview

Acceleron Prices 5.58M Share IPO at $15.00/Share

Share:

Acceleron Pharma, Inc. today announced the pricing of its initial public
offering of 5,580,000 shares of common stock at a public offering price
of $15.00 per share, before underwriting discounts. In addition,
Acceleron has granted the underwriters a 30-day option to purchase up to
an additional 837,000 shares of common stock at the public offering
price, less underwriting discounts. Separately, in a concurrent,
side-by-side private placement, Acceleron's collaboration partner,
Celgene Corporation (NASDAQ: CELG), has agreed to purchase 666,667 shares
of common stock from Acceleron at the public offering price. Acceleron's
common stock has been approved for listing on the NASDAQ Global Market
and is expected to begin trading under the ticker symbol “XLRN” on
September 19, 2013.

See full press release

Posted-In: News Guidance Contracts Management IPOs Global

 

Related Articles (CELG + XLRN)

View Comments and Join the Discussion!
Loading...
Loading...